PCI Registry at University Hospital Basel for Complex Coronary Procedures
Official title: PCI Registry Basel
Run by University Hospital, Basel, Switzerland · NCT07814157 · Data updated 2026-11-12
This registry collects real-world data from adults undergoing percutaneous coronary interventions at University Hospital Basel to see how different treatments like drug-eluting stents, drug-coated balloons, and bioresorbable scaffolds perform in diverse patients.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 10000 (estimated) |
| Sponsor | University Hospital, Basel, Switzerland Academic / other |
| Locations | 1 site (Basel, Canton of Basel-City) |
| Status | Recruiting |
| Started | October 1, 2025 |
| Main results expected | October 2035 |
| Study ends | October 2035 |
| Registry record updated | September 10, 2026 |
| Trial ID | NCT07814157 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults treated with PCI at University Hospital Basel, including those undergoing complex PCI, CTO/CHIP procedures, or treated with a DCB or a BRS.
✕Probably not a fit
Patients who do not undergo the specific therapies studied or who are not part of the registry may not directly benefit from the findings.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PCI Registry Basel is an observational registry that gathers routine clinical data from adults undergoing PCI at University Hospital Basel. It aims to compare outcomes across treatment strategies, including DES, DCB, and BRS, across a spectrum of complex procedures such as CTOs and bifurcations. Data are retrospectively extracted from existing medical records and catheterization lab reports, with no extra interventions or visits required for participation. All information is pseudonymised before analysis, and a secure code link to identifiers is kept separate under control of the Principal Investigator. The study seeks to identify which strategies work best for different patient groups in routine clinical practice to inform future care.
Why it matters
Potential benefit: If successful, findings could help guide doctors in choosing the most effective PCI approaches for various coronary disease patterns.
How similar studies have gone: Observational PCI registries have contributed meaningful real-world insights into device performance and outcomes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Patients treated at the University Hospital Basel * Undergoing complex PCI (e.g. left main, bifurcation, multivessel PCI, rotational atherectomy or other calcium modification, complex anatomy). The definition complex will be a clinical/ procedural/ anatomical definition made by the operator. * Undergoing CTO or CHIP (Complex High-risk Indicated Patient) procedures * Treated with a DCB strategy * Treated with a BRS Exclusion Criteria: * Patients under 18 years of age
Where it's running
-
University Hospital Basel
Basel, Canton of Basel-City, Switzerland Recruiting
Study contacts
- Principal investigator: Gregor Leibundgut, Prof. Dr. med. — University Hospital, Basel, Switzerland
- Study coordinator: Gregor Leibundgut, Prof. Dr. med.
- Email: gregor.leibundgut@usb.ch
- Phone: (0)61 556 58 18
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
QFR-guided virtual stenting to optimize PCI before the procedure
We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.
-
Comparing two ways to open chronic total coronary artery blockages: antegrade dissection-and-reentry versus retrograde approach.
This test will compare whether the antegrade dissection-and-reentry or the retrograde approach works better and is safer for people with difficult chronic total coronary occlusions who need PCI.
-
Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients
This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.
-
AI platform for CT coronary angiography applications
This study is testing a new AI platform that helps doctors quickly and accurately analyze heart scans for patients with coronary artery disease to improve their treatment and care.
-
Comparing heart surgery and medical management for patients with aortic stenosis and coronary artery disease
This study is testing whether combining heart surgery with medical treatment is better for patients who have both aortic stenosis and coronary artery disease.
-
Evaluating the effectiveness of the DESyne X2 coronary stent in clinical practice
This study is testing how well the DESyne X2 stent works for people with blocked arteries who are getting a heart procedure.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.